ARCHIVES

Letter to the Editor: Gensia Official Says No “Threat” Implied In Question Study

This article is from The Cancer Letter archive.

Vol. 21 No. 21 | May 26, 1995

Download PDF Visit The Full Archive

Related Articles

FDA Committee Agenda Includes M-AMSA, THC, Estramustine, Platinum

May 22, 1981

NIH Begins Undiagnosed Diseases Program.

May 30, 2008

Shorter Hospital Stay After Robot-Assisted Surgeries

February 27, 2009

Cancer Drugs Initiatives To Shorten approval Times, Ensure Post-Marketing Studies, FDA Official Says

April 26, 1996

Bristol-Lyers Squibb, Axion In Joint Venture To Sell Oncology Drugs to Office-Base Practices

September 3, 1993

In Brief: Bresnick Directs Norris Cotton Cancer Center; FASEB Honors Kirschstein; Van Nevel’s 2th Year

February 5, 1993